PharmaSols is the oldest and best-connected privately-owned Clinical Research Organisation in the Pacific region. Having successfully supported patient needs and delivered outstanding clinical trial results for more than 20 years, our addition to the global group HiRO in November 2021 means we now provide flexible end-to-end integrated solutions to sponsors around the globe.
PharmaSols offer a global solution which includes:
A flexible global solution providing high-quality results – a one-stop-shop for all critical processes involved with clinical trials.
Biotechs often struggle to develop internally drug development pathways that streamline the entrance of new drugs and devices to market. As part of the global HiRO group, PharmaSols has access to a network of organisations that are critical in the drug development pathway, providing integrated end to end clinical trial solutions.
HiRO recently entered into two new strategic agreements that add further expertise and resource to this network.
Biopharmaceutical manufacturer Peking University Biologics (PKU BIO)
Risk-Based Quality Management system CluePoints
As an established CRO in Australia and New Zealand, PharmaSols is recognised for its capabilities and expertise in conducting both early and later phase trials in the AU NZ region. We are known for rapid study start-up timelines as short as 35 days, cost-effective patient recruitment outcomes, and FDA/EMA-recognised quality data.
As part of the global HiRO group, PharmaSols can leverage an ever-expanding global reach to provide global support for later phase clinical trials and further reduce development timelines for sponsors. The global HiRO group is well established in China and Taiwan and is in the process of expanding to several other countries.
Early phase trials being pulled into AU NZ
“The AU NZ region is seeing extraordinary growth in early phase clinical trials as global sponsors are seeing the regions benefits in rapid start-up. Now with our relationships with HiRO we can offer global sponsors other geographic regions where larger patient populations are required for some later phase trials. Every clinical trial is different, we recognise this and provide a range of flexible solutions.”
Jacquie Palmer PharmaSols Managing Director
With over 20 years of experience in Australia and New Zealand, we have established a trusted network of experts in this region and can now offer even more flexibility in providing solutions for sponsors. Get in touch with us to see how we can help support your trial, from beginning to end.
September 2022 (1)
August 2022 (1)
July 2022 (1)
June 2022 (1)
May 2022 (1)
April 2022 (1)
March 2022 (1)
January 2022 (1)
December 2021 (1)
November 2021 (1)
October 2021 (2)
September 2021 (2)
August 2021 (3)
July 2021 (3)
June 2021 (2)
May 2021 (1)
April 2021 (2)
March 2021 (1)
February 2021 (1)
December 2020 (5)
November 2020 (1)
October 2020 (5)
September 2020 (1)
August 2020 (2)
May 2020 (5)